FDA Approval Insights: Nivolumab/Cabozantinib in Advanced RCC
Season 4, Episode 25, Jan 25, 2021, 09:04 PM
In our exclusive interview, Toni K. Choueiri, MD, provides additional perspective on the FDA approval of nivolumab and cabozantinib in advanced RCC.